[Bronchoalveolar lavage in cytostatic drug-induced lung changes].
Fibrosing alveolitides are associated with a characteristic cellular pattern in the BAL fluid. In contrast, acute interstitial fibrosing pulmonary changes in patients receiving cytostatic drug treatment cannot be detected in the BAL fluid, since the direct influence of cytostatic agents on the cellular constitution of the BAL fluid predominates.
Petermann
W
W
I. Medizinische Universitätsklinik, St. Josefskrankenhaus, Paderborn.
Zurborn
K
K
Barth
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007958:Leukocyte Count; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010954:Plasmacytoma / Q000188:drug therapy*; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
D000970:Antineoplastic Agents
Die BAL bei Zytostatika-induzierten Lungenveränderungen.